[{"Assets_0_Q2_USD":41733000000.0,"CommonStockSharesOutstanding_0_Q2_shares":348516280.0,"EarningsPerShareBasic_1_Q2_USD":-0.11,"EarningsPerShareBasic_2_Q2_USD":1.69,"EarningsPerShareDiluted_1_Q2_USD":-0.11,"EarningsPerShareDiluted_2_Q2_USD":1.68,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1222000000.0,"StockholdersEquity_0_Q2_USD":3931000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":350100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":350900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":350100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":350000000.0,"Ticker":"BHC","CIK":"885590","name":"VALEANT PHARMACEUTICALS INTERNATIONAL, INC.","OfficialName":"Bausch Health Companies Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7962573421.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20170808"}]